Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
01/2013
01/02/2013CN101721387B Calcium carbonate effervescing agent and preparation method thereof
01/02/2013CN101687879B 5-furopyridinone substituted indazoles
01/02/2013CN101597216B Brominated PTP1B inhibitor as well as synthesis method and application thereof in preparation of medicine for curing type 2 diabetes
01/02/2013CN101485698B Novel use of Scaphium scaphigerum extract
01/02/2013CN101474346B Longstamen onion bulb extract as well as preparation method and application thereof
01/02/2013CN101454005B Thiazolidinedione analogues for the treating metabolic inflammation mediated disease
01/02/2013CN101233145B Agent for amelioration of insulin resistance
01/02/2013CN101147749B Divaricate velvetplant medicinal preparation for treating diabetes
01/01/2013US8344003 2-pyridinecarboxamide derivatives
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343927 Pharmaceutical compositions for prevention of overdose or abuse
01/01/2013US8343549 Therapeutic uses of Dunaliella powder
01/01/2013US8343543 Lipase inhibiting composition
01/01/2013US8343540 Process for producing fenofibrate tablets
01/01/2013US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family
12/2012
12/27/2012WO2012178142A1 Ppar-sparing compounds and combinations fort the treatment of diabetes and other metabolic diseases
12/27/2012WO2012178022A2 Therapeutic applications targeting sarm1
12/27/2012WO2012177746A1 Methods of preventing or treating disease states related to certain metabolic abnormalities
12/27/2012WO2012177741A1 Pcsk9-binding polypeptides and methods of use
12/27/2012WO2012177593A2 Method for treating obesity
12/27/2012WO2012177443A2 Glucagon/glp-1 receptor co-agonists
12/27/2012WO2012177215A1 Improved food composition
12/27/2012WO2012177214A1 Liquid pharmaceutical composition comprising nitisinone
12/27/2012WO2012176842A1 Reduced coenzyme q10 crystal having excellent stability
12/27/2012WO2012176804A1 Glucopyranosyloxypyrazole derivative
12/27/2012WO2012176009A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012WO2012175715A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
12/27/2012WO2012175714A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
12/27/2012WO2012175707A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
12/27/2012WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors
12/27/2012WO2012136204A3 Preparation for improving the alcohol metabolism
12/27/2012WO2012135597A3 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair
12/27/2012WO2012135422A3 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
12/27/2012WO2012127037A3 A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
12/27/2012US20120331575 Transgenic non-human animals
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329877 Cycloalkyl-dione Derivatives And Methods Of Their Use
12/27/2012US20120329876 Method and composition for stable and controlled delivery of (-)-hydroxycitric acid
12/27/2012US20120329872 Ready-To-Eat Feed For Domestic Pets
12/27/2012US20120329862 Novel compound having inhibitory effect on lipase
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329848 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
12/27/2012US20120329844 Valsartan salts
12/27/2012US20120329829 Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications
12/27/2012US20120329803 Dihydropteridinones, method for production and use thereof
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329792 IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES
12/27/2012US20120329786 Compounds and therapeutic uses thereof
12/27/2012US20120329782 Azepine inhibitors of janus kinases
12/27/2012US20120329776 Heterocyclic compounds and uses thereof
12/27/2012US20120329749 Methods Of Preventing Or Treating Disease States Related To Certain Metabolic Abnormalities
12/27/2012US20120329748 Activation and activators of sirt5
12/27/2012US20120329736 Treatment for gastrointestinal disorders using a selective, site-activated binding system
12/27/2012US20120329735 Lifespan extending agent
12/27/2012US20120329734 Mixture and infusion or drink solution
12/27/2012US20120329732 Benzylbenzene derivatives and methods of use
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329715 Glp-1, exendin-4, peptide analogs and uses thereof
12/27/2012US20120329711 Glp-1 receptor agonist compounds with a modified n-terminus
12/27/2012US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
12/27/2012US20120329708 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329707 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329703 Potent and Selective Mediators of Cholesterol Efflux
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120328720 Iridoid Based Formulations
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328715 Prevention and treatment of osteochondrosis in animals and humans
12/27/2012US20120328675 Film preparation containing medicament with unpleasant taste
12/27/2012US20120328636 Kdr peptides and vaccines comprising the same
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328634 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/27/2012US20120328630 Methods for treating and/or limiting development of diabetes
12/27/2012US20120328616 Human antigen binding proteins that bind to a complex comprising beta-klotho and an fgf receptor
12/27/2012US20120328598 Agents and mechanisms for treating hypercholesterolemia
12/27/2012US20120328594 Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
12/27/2012US20120328592 Stabilized alpha-galactosidase and uses thereof
12/27/2012US20120328589 Glucocerebrosidase multimers and uses thereof
12/27/2012US20120328582 Primate Embryonic Stem Cells
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012CA2877586A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012CA2876169A1 Methods of preventing or treating disease states related to certain metabolic abnormalities
12/27/2012CA2840360A1 Systems, methods and devices for achieving glycemic balance
12/27/2012CA2840131A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
12/27/2012CA2839867A1 Glucagon/glp-1 receptor co-agonists
12/27/2012CA2839686A1 Glucagon/glp-1 receptor co-agonists
12/27/2012CA2839578A1 Improved food composition
12/27/2012CA2838039A1 Liquid pharmaceutical composition comprising nitisinone
12/27/2012CA2837695A1 Reduced coenzyme q10 crystal having excellent stability
12/27/2012CA2837658A1 Pcsk9-binding polypeptides and methods of use
12/26/2012EP2537523A1 Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents
12/26/2012EP2537422A1 Lifespan extending agent
12/26/2012EP2536733A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
12/26/2012EP2536704A1 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
12/26/2012EP2536694A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase
12/26/2012EP2536419A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
12/26/2012EP2536406A2 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
12/26/2012CN202620249U Calcium ion powder capsule
12/26/2012CN1816536B Regulator of cannabinoid receptor
12/26/2012CN102844316A Azacyclic spiroderivatives as hsl inhibitors
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 1298